{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T10:06:18Z","timestamp":1772273178938,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00192-022-05383-3","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T12:02:58Z","timestamp":1665835378000},"page":"1437-1446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary\u2013Sant symptom index"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2674-8047","authenticated-orcid":false,"given":"Maria Ver\u00f4nica","family":"Pires","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6736-2100","authenticated-orcid":false,"given":"Carlos Jos\u00e9","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0806-4132","authenticated-orcid":false,"given":"Henrique Cunha","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-7596","authenticated-orcid":false,"given":"L\u00edvia Helena","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1794-0790","authenticated-orcid":false,"given":"Adriana Barrinha","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"issue":"6","key":"5383_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/iju.14229","volume":"27","author":"Y Akiyama","year":"2020","unstructured":"Akiyama Y, Luo Y, Hanno MP, et al. Interstitial cystitis\/bladder pain syndrome: The evolving landscape, animal models and future perspectives. Int J Urol. 2020;27(6):491\u2013503. https:\/\/doi.org\/10.1111\/iju.14229.","journal-title":"Int J Urol"},{"issue":"Suppl 1","key":"5383_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/iju.13985","volume":"26","author":"LA Birder","year":"2019","unstructured":"Birder LA. Pathophysiology of interstitial cystitis. Int J Urol. 2019;26(Suppl 1):12\u20135. https:\/\/doi.org\/10.1111\/iju.13985.","journal-title":"Int J Urol"},{"issue":"5","key":"5383_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bju.14399","volume":"122","author":"S Malde","year":"2018","unstructured":"Malde S, Palmisani S, Al-Kaisy A, et al. Guideline of guidelines: bladder pain syndrome. BJU Int. 2018;122(5):729\u201343. https:\/\/doi.org\/10.1111\/bju.14399.","journal-title":"BJU Int"},{"issue":"5-6","key":"5383_CR4","doi-asserted-by":"publisher","first-page":"E136","DOI":"10.5489\/cuaj.3786","volume":"10","author":"A Cox","year":"2016","unstructured":"Cox A, Golda N, Nadeau G, et al. CUA guideline: Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. Can Urol Assoc J. 2016;10(5-6):E136\u201355. https:\/\/doi.org\/10.5489\/cuaj.3786.","journal-title":"Can Urol Assoc J"},{"issue":"5","key":"5383_CR5","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno PM, Erickson D, Moldwin R, et al. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545\u201353. https:\/\/doi.org\/10.1016\/j.juro.2015.01.086.","journal-title":"J Urol"},{"issue":"2","key":"5383_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pop.2019.02.002","volume":"46","author":"MM Huffman","year":"2019","unstructured":"Huffman MM, Slack A, Hoke M. Bladder pain syndrome. Prim Care. 2019;46(2):213\u201321. https:\/\/doi.org\/10.1016\/j.pop.2019.02.002.","journal-title":"Prim Care"},{"issue":"6","key":"5383_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00404-017-4364-2","volume":"295","author":"SS Patnaik","year":"2017","unstructured":"Patnaik SS, Lagan\u00e0 AS, Vitale SG, et al. Etiology, pathophysiology and biomarkers of interstitial cystitis\/painful bladder syndrome. Arch Gynecol Obstet. 2017;295(6):1341\u201359. https:\/\/doi.org\/10.1007\/s00404-017-4364-2.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"5383_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5114\/pm.2020.95334","volume":"19","author":"S Garzon","year":"2020","unstructured":"Garzon S, Lagan\u00e0 AS, Casarin J, et al. An update on treatment options for interstitial cystitis. Menopause Rev. 2020;19(1):35\u201343. https:\/\/doi.org\/10.5114\/pm.2020.95334.","journal-title":"Menopause Rev"},{"key":"5383_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/iju.13969","volume":"1","author":"Y Akiyama","year":"2019","unstructured":"Akiyama Y, Hanno MP. Phenotyping of interstitial cystitis\/bladder pain syndrome. Int J Urol. 2019;1:17\u20139. https:\/\/doi.org\/10.1111\/iju.13969.","journal-title":"Int J Urol"},{"key":"5383_CR10","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/14656566.2018.1491968","volume":"10","author":"LL Giusto","year":"2018","unstructured":"Giusto LL, Zahner PM, Shoskes DA. An evaluation of the pharmacotherapy for interstitial cystitis. Expert Opin Pharmacother. 2018;10:1097\u2013108. https:\/\/doi.org\/10.1080\/14656566.2018.1491968.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"5383_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.eururo.2018.07.026","volume":"74","author":"PC Bosch","year":"2018","unstructured":"Bosch PC. A randomized, double-blind, placebo-controlled trial of certolizumab pegol in women with refractory interstitial cystitis\/bladder pain syndrome. Eur Urol. 2018;74(5):623\u201330. https:\/\/doi.org\/10.1016\/j.eururo.2018.07.026.","journal-title":"Eur Urol"},{"issue":"3","key":"5383_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/biom11030356","volume":"11","author":"A Sire","year":"2021","unstructured":"Sire A, Agostini F, Lippi L, et al. Oxygen-ozone therapy in the rehabilitation field: state of the art on mechanisms of action, safety and effectiveness in patients with musculoskeletal disorders. Biomolecules. 2021;11(3):356. https:\/\/doi.org\/10.3390\/biom11030356.","journal-title":"Biomolecules"},{"key":"5383_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-9234-2","volume-title":"Ozone: A New Medical Drug","author":"V Bocci","year":"2011","unstructured":"Bocci V. Ozone: A New Medical Drug. 2nd ed. Dordrecht: Springer; 2011. https:\/\/doi.org\/10.1007\/978-90-481-9234-2.","edition":"2"},{"issue":"3","key":"5383_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/ijms20030634","volume":"20","author":"R Di Mauro","year":"2019","unstructured":"Di Mauro R, Cantarella G, Bernardini R, et al. The biochemical and pharmacological properties of ozone: the smell of protection in acute and chronic diseases. Int J Mol Sci. 2019;20(3):634. https:\/\/doi.org\/10.3390\/ijms20030634.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5383_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1089\/acm.2011.0739","volume":"19","author":"J Hidalgo-Tall\u00f3n","year":"2013","unstructured":"Hidalgo-Tall\u00f3n J, Cepero SM, Vilchez JS, et al. Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: An open-label pilot study. J Altern Complement Med. 2013;19(3):238\u201342. https:\/\/doi.org\/10.1089\/acm.2011.0739.","journal-title":"J Altern Complement Med"},{"key":"5383_CR16","doi-asserted-by":"publisher","unstructured":"Tirelli U, Cirrito C, Pavanello M. Ozone therapy in 40 patients with fibromyalgia: an effective therapy. Ozone. Therapy. 2018;3(3). https:\/\/doi.org\/10.4081\/ozone.2018.7969.","DOI":"10.4081\/ozone.2018.7969"},{"issue":"2","key":"5383_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4103\/0974-7796.130553","volume":"6","author":"O Bayrak","year":"2014","unstructured":"Bayrak O, Erturhan S, Seckiner I, et al. Chemical cystitis developed in experimental animals model: Topical effect of intravesical ozone application to bladder. Urol Ann. 2014;6(2):122\u20136. https:\/\/doi.org\/10.4103\/0974-7796.130553.","journal-title":"Urol Ann"},{"issue":"1","key":"5383_CR18","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.25011\/cim.v36i1.19400","volume":"36","author":"S Tasdemir","year":"2013","unstructured":"Tasdemir S, Tasdemir C, Vardi N, et al. Effects of ozone therapy on cyclophosphamide-induced urinary bladder toxicity in rats. Clin Invest Med. 2013;36(1):E9\u201317. https:\/\/doi.org\/10.25011\/cim.v36i1.19400.","journal-title":"Clin Invest Med"},{"issue":"3","key":"5383_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1538\/expanim.16-0093","volume":"66","author":"K Teke","year":"2017","unstructured":"Teke K, Ozkan TA, Cebeci OO, et al. Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats. Exp Anim. 2017;66(3):191\u20138. https:\/\/doi.org\/10.1538\/expanim.16-0093.","journal-title":"Exp Anim"},{"key":"5383_CR20","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.biopha.2018.07.137","volume":"107","author":"A Wei","year":"2018","unstructured":"Wei A, Feng H, Jia X, et al. Ozone therapy ameliorates inflammation and endometrial injury in rats with pelvic inflammatory disease. Biomed Pharmacother. 2018;107:1418\u201325. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.137.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"5383_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0090-4295(99)80333-1","volume":"49","author":"MP O'Leary","year":"1997","unstructured":"O'Leary MP, Sant GR, Fowler FJ, et al. The interstitial cystitis symptom index and problem index. Urol. 1997;49(5):58\u201363. https:\/\/doi.org\/10.1016\/S0090-4295(99)80333-1.","journal-title":"Urol"},{"issue":"5","key":"5383_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/17512433.2018.1457435","volume":"11","author":"T Ogawa","year":"2018","unstructured":"Ogawa T, Ishizuka O, Ueda T, et al. Pharmacological management of interstitial cystitis \/bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play. Expert Rev Clin Pharmacol. 2018;11(5):495\u2013505. https:\/\/doi.org\/10.1080\/17512433.2018.1457435.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6 Suppl 1","key":"5383_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/s0090-4295(01)01126-8","volume":"57","author":"DP Lubeck","year":"2001","unstructured":"Lubeck DP, Whitmore K, Sant GR, et al. Psychometric validation of the O\u2019Leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urol. 2001;57(6 Suppl 1):62\u20136. https:\/\/doi.org\/10.1016\/s0090-4295(01)01126-8.","journal-title":"Urol"},{"key":"5383_CR24","unstructured":"Schwartz A, S\u00e1nchez GM, Sabbah F et al. Madrid Declaration on Ozone Therapy. 3rd Ed. International Scientific Committee of Ozone Therapy. 2020. https:\/\/www.isco3.org. Accessed 10 May 2022."},{"issue":"6","key":"5383_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/01919512.2012.717847","volume":"34","author":"R Viebahn-H\u00e4nsler","year":"2012","unstructured":"Viebahn-H\u00e4nsler R, Le\u00f3n Fern\u00e1ndez OS, Fahmy Z. Ozone in medicine: The low-dose ozone concept\u2014guidelines and treatment strategies. Ozone-Sci Eng. 2012;34(6):408\u201324. https:\/\/doi.org\/10.1080\/01919512.2012.717847.","journal-title":"Ozone-Sci Eng"},{"key":"5383_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/13697137.2015.1078206","volume":"1","author":"J Calleja-Agius","year":"2015","unstructured":"Calleja-Agius J, Brincat MP. The urogenital system and the menopause. Climacteric. 2015;1:18\u201322. https:\/\/doi.org\/10.3109\/13697137.2015.1078206.","journal-title":"Climacteric"},{"issue":"1","key":"5383_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12894-019-0548-3","volume":"19","author":"H Shan","year":"2019","unstructured":"Shan H, Zhang EW, Zhang P, et al. Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome\/ interstitial cystitis \u2013 significance in the responsiveness to antihistamine treatment and disease symptoms. BMC Urol. 2019;19(1):115. https:\/\/doi.org\/10.1186\/s12894-019-0548-3.","journal-title":"BMC Urol"},{"issue":"3","key":"5383_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10517-014-2358-7","volume":"156","author":"AI Neimark","year":"2014","unstructured":"Neimark AI, Nepomnyashchikh LM, Lushnikova EL, et al. Microcirculation and structural reorganization of the bladder mucosa in chronic cystitis under conditions of ozone therapy. Bull Exp Biol Med. 2014;156(3):399\u2013405. https:\/\/doi.org\/10.1007\/s10517-014-2358-7.","journal-title":"Bull Exp Biol Med"},{"issue":"4","key":"5383_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s001920170049","volume":"12","author":"A Hextall","year":"2001","unstructured":"Hextall A, Cardozo L. The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(4):258\u201361. https:\/\/doi.org\/10.1007\/s001920170049.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"2","key":"5383_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.genhosppsych.2011.01.004","volume":"33","author":"KE Watkins","year":"2011","unstructured":"Watkins KE, Eberhart N, Hilton L, et al. Depressive disorders and panic attacks in women with bladder pain syndrome\/interstitial cystitis: A population-based sample. Gen Hosp Psychiatry. 2011;33(2):143\u20139. https:\/\/doi.org\/10.1016\/j.genhosppsych.2011.01.004.","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"5383_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/24740527.2020.1785854","volume":"4","author":"LC McKernan","year":"2020","unstructured":"McKernan LC, Bonnet KR, Finn MTM, et al. Qualitative analysis of treatment needs in interstitial cystitis\/ bladder pain syndrome: Implications for intervention. Can J Pain. 2020;4(1):181\u201398. https:\/\/doi.org\/10.1080\/24740527.2020.1785854.","journal-title":"Can J Pain"},{"issue":"11-12","key":"5383_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5489\/cuaj.3892","volume":"10","author":"DA Tripp","year":"2016","unstructured":"Tripp DA, Nickel JC, Krsmanovic A, et al. Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis\/bladder pain syndrome. Can Urol Assoc J. 2016;10(11-12):383\u20138. https:\/\/doi.org\/10.5489\/cuaj.3892.","journal-title":"Can Urol Assoc J"},{"issue":"9","key":"5383_CR33","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1093\/pm\/pnaa459","volume":"22","author":"B Clavo","year":"2021","unstructured":"Clavo B, Navarro M, Federico M, Borrelli E, et al. Long-term results with adjuvant ozone therapy in the management of chronic pelvic pain secondary to cancer treatment. Pain Med. 2021;22(9):2138\u201341. https:\/\/doi.org\/10.1093\/pm\/pnaa459.","journal-title":"Pain Med"},{"issue":"4","key":"5383_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/21681805.2014.982170","volume":"49","author":"J Quaghebeur","year":"2015","unstructured":"Quaghebeur J, Wyndaele J. Bladder pain syndrome (BPS): Symptom differences between type 3C BPS and non-type 3C BPS. Scand J Urol. 2015;49(4):319\u201320. https:\/\/doi.org\/10.3109\/21681805.2014.982170.","journal-title":"Scand J Urol"},{"issue":"1","key":"5383_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/00365599.2012.699100","volume":"47","author":"Y Logadottir","year":"2013","unstructured":"Logadottir Y, Hallsberg L, Fall M, et al. Bladder pain syndrome\/interstitial cystitis ESSIC type 3C: High expression of inducible nitric oxide synthase in inflammatory cells. Scand J Urol. 2013;47(1):52\u20136. https:\/\/doi.org\/10.3109\/00365599.2012.699100.","journal-title":"Scand J Urol"},{"issue":"4","key":"5383_CR36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bcp.2011.11.025","volume":"83","author":"S Schulz","year":"2012","unstructured":"Schulz S, Ninke S, Watzer B, et al. Ozone induces synthesis of systemic prostacyclin by cyclooxygenase-2 dependent mechanism in vivo. Biochem Pharmacol. 2012;83(4):506\u201313. https:\/\/doi.org\/10.1016\/j.bcp.2011.11.025.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"5383_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1590\/S0102-86502015001000008","volume":"30","author":"B Xing","year":"2015","unstructured":"Xing B, Chen H, Wang L, et al. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury via modulation of the TLR4-NF-\u03baB pathway. Acta Cir Bras. 2015;30(1):60\u20136. https:\/\/doi.org\/10.1590\/S0102-86502015001000008.","journal-title":"Acta Cir Bras"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05383-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-022-05383-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-022-05383-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:19:32Z","timestamp":1744143572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-022-05383-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["5383"],"URL":"https:\/\/doi.org\/10.1007\/s00192-022-05383-3","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}